Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 68,324,678.87
    Countries
    Sector(s)
    Iceland : € 68,324,678.87
    Industry : € 68,324,678.87
    Signature date(s)
    27/03/2020 : € 68,324,678.87
    Link to source

    Summary sheet

    Release date
    9 June 2020
    Status
    Reference
    Signed | 27/03/2020
    20190524
    Project name
    Promoter - financial intermediary
    OESSUR MEDICAL TECHNOLOGY RDI
    OESSUR HF
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    USD 75 million (EUR 67 million)
    USD 156 million (EUR 139 million)
    Location
    Sector(s)
    Description
    Objectives

    The project concerns the promoter's R&D investments for innovative prosthetics and bracing solutions.

    The RDI activities focus on innovative solutions in prosthetics and orthotics that can help people regain or maintain their mobility.

    Environmental aspects
    Procurement

    RDI activities included in the project will not materially change current R&D practice and will be carried out within existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal.

    The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement.

    Link to source

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - OESSUR MEDICAL TECHNOLOGY RDI
    Publication Date
    26 Jun 2020
    Document language
    Main Topic
    Lending
    Document Number
    122892823
    Document Focus
    Environmental Information
    Project Number
    20190524
    Sector(s)
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications